Erythropoietin treatment and osteoporotic fracture risk in hemodialysis patients: A nationwide population-based study
Our findings suggest that EPO treatment in patients with ESRD undergoing hemodialysis is associated with an increased risk of osteoporotic fractures.
Authors
- Chih‐Ching Yeh (ORCID: https://orcid.org/0000-0001-6483-1100)
- Peir‐Haur Hung (ORCID: https://orcid.org/0000-0002-5963-6981)
- Ching‐Yu Lee (ORCID: https://orcid.org/0000-0001-6118-1667)
- Meng–Huang Wu (ORCID: https://orcid.org/0000-0003-1606-2444)
- Tsung‐Jen Huang (ORCID: https://orcid.org/0000-0002-3640-3018)
- Fung-Chang Sung
- Chih-Hsin Muo
Institutions
- Asia University (TW)
- China Medical University (TW)
- Taipei Medical University Hospital (TW)
- Chia-Yi Christian Hospital (TW)
- China Medical University Hospital (TW)
- Wan Fang Hospital (TW)
- Taipei Medical University (TW)
- Chia Nan University of Pharmacy and Science (TW)
Publication Details
- Journal
- Osteoporosis and Sarcopenia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1016/j.afos.2024.11.002
- Citations
- 1
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.11
Funders
- China Medical University Hospital
- China Medical University
- National Science and Technology Council
- Division of Materials Research